7799.TW Heron Neutron Medical Corp.
- Market cap
- TWD 64.2B
- P/E
- -
- P/B
- 5.75x
- ROE
- -3.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 7799.TW undervalued?
Graham numberThe Graham number of Heron Neutron Medical Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Heron Neutron Medical Corp. fundamental analysis
No fundamental analysis for Heron Neutron Medical Corp. yet.
Heron Neutron Medical Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Heron Neutron Medical Corp.
Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.
Full company profileHeron Neutron Medical Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Heron Neutron Medical Corp. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0.00 | 238K | 0.00 | 10.3M | 6.78M |
| Gross Profit | 0.00 | 129K | -3.59M | -25.8M | -15.2M |
| Operating Income | -87.8M | -130M | -259M | -534M | -462M |
| EBITDA | -71.9M | -111M | -239M | -441M | -275M |
| Net Income | -86.2M | -126M | -260M | -482M | -330M |
| EPS | -0.61 | -0.90 | -1.85 | -3.06 | -2.09 |
| Balance Sheet | |||||
| Total Assets | 631M | 835M | 1.54B | 11.6B | 11.5B |
| Total Liabilities | 40.6M | 28.7M | 72.0M | 89.3M | 329M |
| Shareholders' Equity | 590M | 806M | 1.47B | 11.5B | 11.2B |
| Cash & Short-term Investments | 7.87M | 233M | 724M | 2.35B | 536M |
| Cash Flow | |||||
| Operating Cash Flow | -62.0M | -54.6M | -260M | -484M | -864M |
| Capital Expenditure | 114M | 56.2M | 49.0M | 30.1M | 57.9M |
| Free Cash Flow | -176M | -111M | -309M | -514M | -922M |
| Ratios | |||||
| ROE | -14.6% | -15.7% | -17.7% | -4.2% | -3.0% |
| ROA | -13.7% | -15.1% | -16.8% | -4.2% | -2.9% |
| Net Profit Margin | - | -53,105.0% | - | -4,672.7% | -4,868.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Heron Neutron Medical Corp. dividends
Heron Neutron Medical Corp. has not paid dividends in the last 4 fiscal years.
Who owns Heron Neutron Medical Corp.
- Insiders 68.48%
- Institutions 2.25%
- Public & others 29.27%
- Shares outstanding 158M
- Free float 51.2M
Heron Neutron Medical Corp. company profile
- Company name
- Heron Neutron Medical Corp.
- Ticker
- 7799.TW
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 104
- Fiscal year end
- December
- Address
- No. 66-2, Shengyi 5th Road, Zhubei, Taiwan, 302041
- Phone
- 886 3 561 9366
- Website
- heron-neutron.com
About Heron Neutron Medical Corp.
Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and is based in Zhubei, Taiwan.
Heron Neutron Medical Corp. management
5- Mr. Xiao-Lian ShenGeneral Manager
- Mr. Wenzhen WangCFO & Deputy GM
- Mr. Yan-Da WuDeputy General Manager of the Career Development Center
- Mr. Cheng-sung LinDeputy General Manager of the Clinical Medical Center
- Mr. Wei-Lin ChenDeputy General Manager of the R&D Engineering Center